Skip to search formSkip to main contentSkip to account menu

Non-Steroidal Aromatase Inhibitor

Known as: Non-Steroidal Androstenedione Aromatase Inhibitor, Non-Steroidal Estrogen Synthetase Inhibitor, Non-Steroidal Estrogen Synthase Inhibitor 
A family of drugs that decrease the production of sex hormones (estrogen or testosterone) and slow the growth of tumors that need sex hormones to… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract P6-18-04: Ribociclib with a non-steroidal aromatase inhibitor and goserelin in premenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer: MONALEESA-7 age…
Background: Younger patients (pts) with breast cancer may experience more aggressive disease and are more likely to die from… 
2018
2018
Effect of aromatase inhibitor (fadrozole) on proliferation, estradiol production and telomerase activity in pig granulosa cells in vitro.
The objective of the present work was to study the effect of a nonsteroidal aromatase inhibi - tor (fadrozole) on proliferation… 
Review
2016
Review
2016
Aromatase Inhibitors: A Safer Approach for the Treatment of Breast Cancer
Breast cancer is the second leading cause of cancer death in women. About two-thirds of breast cancers are termed hormone… 
Review
2014
Review
2014
[The drug of the month: everolimus (Afinitor) for the treatment of metastatic breast cancer].
Sequential endocrine treatments are recommended for estrogen receptor (ER) positive human epidermal growth factor receptor 2 (HER… 
2013
2013
Abstract P2-16-17: Characterization of response to everolimus (EVE) in BOLERO-2: A phase 3 trial of EVE plus exemestane (EXE) in postmenopausal women with HR+, HER2- advanced breast cancer
Introduction: The BOLERO-2 trial demonstrated that combining the oral mammalian target of rapamycin (mTOR) inhibitor, EVE, with… 
Review
2013
Review
2013
Development of a non-steroidal aromatase inhibitor-based protocol for the control of ovarian function using a bovine model
............................................................................................................. ii ACKNOWLEDGEMENTS… 
2009
2009
Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor.
Anastrozole, a selective nonsteroidal aromatase inhibitor is widely used as an adjuvant therapy for postmenopausal women with… 
2007
2007
Dehydroepiandrosterone sulfate is neuroprotective in a focal cortical cold lesion model
Dehydroepiandrosterone and its sulfate (DHEAS) are sex hormone precursors. They may function as neurotrophic or neuroprotective… 
Review
2000
Review
2000
Activity o f E xemestane i n M etastatic B reast C ancer After F ailure o f N onsteroidal A romatase I nhibitors: A P hase I I T rial
Purpose: To evaluate the antitumor activity and toxicity of a new steroidal aromatase inactivator, exemestane, in postmenopausal… 
Review
1997
Review
1997
Anastrozole: a new selective nonsteroidal aromatase inhibitor.
Endocrine therapy has long been a mainstay in the therapy of metastatic breast cancer and in the adjuvant setting. The…